TECH
Bio-Techne Corp.
stockNASDAQ
bio-techne (formerly techne corp.), nasdaq: tech, is a global life sciences company providing innovative bioactive tools and resources for the research and clinical diagnostic communities. bio-techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. they aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. with over 275,000 products in its portfolio, bio-techne generated approximately $358 million in net sales in fy 2014 and has over 1,000 employees worldwide.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 72.51 | 2026-09-28 | -0.13% | 0.018 |
| 1M | 72.43 | 2026-09-04 | -0.02% | 0.085 |
| 3M | 70.92 | 2026-07-06 | +2.11% | 0.063 |
| 6M | 53.80 | 2026-04-06 | +34.60% | 0.478 |
| 1Y | 62.95 | 2025-10-03 | +15.04% | 0.788 |
| 2Y | 74.78 | 2024-10-04 | -3.16% | — |
| 5Y | 120.31 | 2021-10-04 | -39.81% | 1.122 |
Bio-Techne Corp. (NASDAQ:TECH) stock price today is $72.42, and today's volume is 1,866,663. TECH is up 0.021% today. The 30 day average volume is 2.81M. TECH market cap is $11.36B with 156.82M shares outstanding.